YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
NEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Tidal Financial Group and Defiance ETFs today announced their decision to close and liquidate eight exchange-traded funds listed on the Nasdaq: Defiance Leveraged Long + Income PLTR ETF (Nasdaq:…
Canadians are behind Ottawa’s push to develop critical minerals in this country, but when it comes to who will pay for it, that’s when things get sticky. Almost 60 per cent of Canadians polled by the Angus Reid Institute consider losing so…
An exchange-traded fund tracking trillion dollar assets, including tech and crypto-related companies and products, debuted on Tuesday, the latest ETF to give U.S. investors exposure to the fast-growing digital asset and AI space. Miami, Fl…
Mr. Parsons served as the Chief Financial Officer of Trillium Therapeutics, which was recently acquired by Pfizer Inc. SAN DIEGO and CALGARY, AB, June 17, 2022 /CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), today announced th…
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge funds and institutional investors spend millions of dollars on analysts with MBAs and PhD…
If we broadly classify stocks, we end up with two major categories. The first is growth stocks. Typically, these are stocks to buy from companies with robust revenue and earnings growth. Most of these companies have high capital expenditur…
In this article you are going to find out whether hedge funds think Radius Health Inc (NASDAQ:RDUS) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Althou…
CAMBRIDGE, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, is pleas…
CAMBRIDGE, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, is pleas…
CAMBRIDGE, Mass., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today an…
CAMBRIDGE, Mass., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today an…
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money managers and analyze their quarterly 13F filings. The stocks tha…
Big money is pouring into two disruptive segments in two of the world’s biggest industries - healthcare and energy. Both these have been undergoing continual digital disruption … But there’s more to come. In healthcare and wellness, global…
A massive disruption now appears imminent in one of the world’s largest – and most important – industries. In much the same way that Amazon disrupted the retail business – and how PayPal disrupted the payments industry – one under-the-rada…
The big shareholder groups in Trillium Therapeutics Inc. (TSE:TRIL) have power over the company. Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions as shareholders. Companies that…
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors are starting to get cautious towards the current bull run sin…
NEW YORK, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Great Western Bancorp, Inc. (NYSE: GWB) concerning potential violations of the federal…
NEW YORK, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Great Western Bancorp, Inc. (NYSE: GWB) concerning potential violations of the federal…
NEW YORK, Sept. 21, 2021 /PRNewswire/ -- WeissLaw LLP (PRNewsfoto/WeissLaw LLP) If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights…
In this article, we discuss the 15 best blue-chip stocks to invest in. If you want to skip our detailed analysis of these companies, go directly to the 5 Best Blue Chip Stocks to Invest In. Many investors consider buying blue-chip stocks t…
NEW YORK, Sept. 17, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: logo (PRNewsfoto/Halper Sadeh LLP) ADTRAN, Inc. (NASDAQ: ADTN) concerning potential violat…
Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today: Arco Platform Limited ARCE develops educational software. The Zacks Consensus Estimate for its current year earnings has been revised 2.3% downward over the last 30…
NEW YORK, Sept. 14, 2021 /PRNewswire/ -- WeissLaw LLP (PRNewsfoto/WeissLaw LLP) If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights…
NEW YORK, Sept. 11, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Columbia Property Trust, Inc. (NYSE: CXP) concerning potential violations of the feder…
NEW YORK, Sept. 11, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Columbia Property Trust, Inc. (NYSE: CXP) concerning potential violations of the feder…
NEW YORK, Sept. 11, 2021 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at…
NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed merg…
NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed merg…
NEW YORK, Sept. 9, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: logo (PRNewsfoto/Halper Sadeh LLP) Inovalon Holdings, Inc. (NASDAQ: INOV) concerning potent…
Curis (NASDAQ: CRIS), a small-cap cancer specialist, posted a healthy gain in August. Curis' shares appeared to be a direct beneficiary of Pfizer's (NYSE: PFE) buyout of Trillium Therapeutics (NASDAQ: TRIL), another small-cap cancer compan…
NEW YORK, Sept. 7, 2021 /PRNewswire/ -- WeissLaw LLP (PRNewsfoto/WeissLaw LLP) If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights…
Pfizer (NYSE: PFE) announced in August that it plans to acquire Trillium Therapeutics (NASDAQ: TRIL) for nearly $2.3 billion. In this Motley Fool Live video recorded on Aug. 25, Motley Fool contributors Keith Speights and Brian Orelli disc…
TORONTO, Sept. 3, 2021 /CNW/ - As a result of the quarterly review, S&P Dow Jones Indices will make the following changes to the S&P/TSX Composite Index prior to the open of trading on Monday, September 20, 2021: S&P/TSX COMPOSITE INDEX –…
Kudos to Pfizer (NYSE: PFE) for its decision to acquire Trillium Therapeutics (NASDAQ: TRIL). The small biotech's cancer pipeline is a great fit for Pfizer. Trillium's candidates could begin contributing to Pfizer's growth in the second ha…
NEW YORK, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Landmark Infrastructure Partners LP (NASDAQ: LMRK) concerning potential violations of…
NEW YORK, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Landmark Infrastructure Partners LP (NASDAQ: LMRK) concerning potential violations of…